The Neighborly Drug Dealer

An Open Dialogue and Update on Azalea Drugs

28 min · 28. mai 2025
Forsidebilde av episoden An Open Dialogue and Update on Azalea Drugs

Beskrivelse

Join us on this special episode of The Neighborly Drug Dealer, as Dr. Morgan Fordham gives an update on Azalea Drugs and the pharmacy construction project.

Kommentarer

0

Vær den første til å kommentere

Registrer deg nå og bli medlem av The Neighborly Drug Dealer sitt community!

Prøv gratis

Prøv gratis i 14 dager

99 kr / Måned etter prøveperioden. · Avslutt når som helst

  • Eksklusive podkaster
  • 20 timer lydbøker i måneden
  • Gratis podkaster

Alle episoder

22 Episoder

Forsidebilde av episoden GLP-1 Crackdown: What the FDA Really Means & Why Compounding Still Matters

GLP-1 Crackdown: What the FDA Really Means & Why Compounding Still Matters

There’s been a lot of noise lately around semaglutide, tirzepatide, and other GLP-1 medications—especially as the FDA cracks down on certain compounded versions. But what’s really going on? And what should patients and providers know? In this solo episode, I unpack the truth behind the headlines. We’ll clarify what GLP-1 medications actually are (hint: they’re not insulin), why they’re in such high demand, and how compounding pharmacies legally stepped in during national shortages. I’ll also break down the difference between 503A and 503B pharmacies and share how to spot quality in compounded meds. Whether you’re a patient, provider, or pharmacy pro, this episode clears the fog around GLP-1s and gives you real tools to stay informed.

8. juli 202534 min